Known cancer up to 5 years prior to stroke represents an independent prognostic cofactor for mortality after stroke with additional prognostic cofactors including low hemoglobin, elevated CRP, pathologic platelet count, female sex and mRS on admission ≥ 4 (Table 3). This evidence concerns the gene CRP and stroke disorder.